The old adage that health care is recession-proof will face a major challenge in 2023. Existing forces, including the exodus of talent from the health care profession and patients with advanced-stage disease returning to the clinic for the first time in several years, will only continue into the new year against a potentially bleak economic backdrop. Expect larger trends shaping the future of work to permeate the health care industry next year. Global business leaders are anticipating an influx of jobs that simply haven't existed before, a result of the anticipated need to integrate emerging technologies alongside tasks traditionally reserved for humans; consider the need for an IT department 40 years ago compared to now, as personal computers dominate office cubicles. Therein lies the need for health care organizations to recruit smart, adaptable students into the profession to meet tomorrow's needs.

Amazon said it will acquire the primary care organization One Medical for $3.9 billion. Amazon said it will acquire the primary care organization One Medical for $3.9 billion. Amazon plans to buy the primary care organization One Medical in a nearly $4 billion deal, adding to the growing list of the tech giant's acquisitions and attempts to expand its reach in the health care industry. "We think health care is high on the list of experiences that need reinvention," Neil Lindsay, senior vice president of Amazon Health Services, said in a statement last week. One Medical is a membership-based primary care practice with nearly 200 locations across the country that also offers virtual services.

Today, artificial intelligence (AI) serves as the engine behind the curtain of personalization, offering new opportunities for better service and improved personal experiences--and health care is no exception. With emerging technologies now making their way into our most established industries, AI has enormous potential to revolutionize health care. The popularity of wearables is on the rise, allowing general practitioners to constantly monitor patients and collect vital data to fine-tune treatments. Not only can doctors benefit from data collected and processed by AI-powered algorithms, but the pharmaceutical industry is also looking to develop a more personalized approach to designing treatments and delivering therapies. The global market for AI-powered software is forecasted to reach $309.6 billion by 2026.

Shannon Flynn is a freelance blogger who covers education technologies, cybersecurity and IoT topics. You can follow Shannon on Muck Rack or Medium to read more of her articles. Artificial intelligence (AI) has had major impacts in the health care industry, affecting providers and patients alike. However, it also aids the pharmaceutical sector in finding and creating the drugs that support health care through the treatment and management of diseases. Here's a closer look at some positive changes AI could bring this year.

This blog post was written by Dr. Maryam S. Jaffer, Director Data and Statistics, Emirates Health Services; Dr. Bashar Balish, Senior Director, Cerner; and Michel Ghorayeb, UAE Managing Director, SAS. The future of health care has never been more exciting. Artificial intelligence (AI) and data analytics have captured center stage for any business planning on surviving and thriving. Given the pace of technological development, AI is transforming the future on an unprecedented scale. And that includes the future of health care.

News of CVS Pharmacy's entry into the metaverse has spurred increased interest in how augmented reality, virtual reality, and artificial intelligence will reshape the health care landscape. A new report from Brookings focuses specifically on AI and acknowledges that it has the potential to make "a large impact" on health care. In the report, Avi Goldfarb (Rotman Chair in Artificial Intelligence and Healthcare, as well as Professor of Marketing at the Rotman School of Management at the University of Toronto) and Florenta Teodoridis (Assistant Professor of Management and Organization at the University of Southern California's Marshall School of Business) cite numerous academic and industry conferences dedicated to the topic, as well as major medical journals and reports from nonprofit organizations, private consultancies, and the U.S. government.

Oracle's gargantuan $28.3 billion acquisition of health care data company Cerner, the largest deal in its 44-year history, is not just about electronic patient records. From algorithmic systems that predict the likelihood a patient will contract sepsis to tech that tracks hospital bed capacity, Cerner will bring an array of cloud-based data analytics and AI technologies to Oracle as it competes with Amazon Web Services, Google, IBM and others to serve the health care industry's data and AI needs. In fact, the deal is poised to shift some business away from AWS, which Cerner named as its preferred cloud partner in 2019. Oracle's acquisition of Cerner, a company that got its start in health care IT in 1979, is expected to close in 2022. The all-cash deal is also expected to improve Oracle's bottom line in its first year, the company said in a press release.

Policymakers around the world are developing guidelines for use of artificial intelligence in health care. Baymax, the robotic health aide and unlikely hero from the movie Big Hero 6, is an adorable cartoon character, an outlandish vision of a high-tech future. But underlying Baymax's character is the very realistic concept of an artificial intelligence (AI) system that can be applied to health care. As AI technology advances, how will regulators encourage innovation while protecting patient safety? AI does not have a precise definition, but the term generally describes machines that have the capacity to process and respond to stimulation in a manner similar to human thought processes.

Her research during the summer of 2021 was done remotely, from her home in Ardsley, New York, with guidance from Max Dolinsky, assistant professor of finance. She reviewed literature examining both the potential and the limitations of algorithm-based analysis for the health care industry. In her summary presentation, Levine said researchers found that AI holds great potential for health care, but also found that many patients and health care systems are not ready to use the powerful technology. Q: What draws you to research? Levine: I believe research can better my knowledge and experience in the topic of health care and that is the field I want to pursue.

Nvidia is launching the $100 million Cambridge-1, the most powerful supercomputer in the United Kingdom, and it is making it available to external researchers in the U.K. health care industry. The machine will be used for AI research in health care, and it's one of the world's fastest supercomputers. Nvidia will make it available to accelerate research in digital biology, genomics, and quantum computing. Nvidia is collaborating with AstraZeneca, maker of one of the COVID-19 vaccines, to fuel faster drug discoveries and creating a transformer-based generative AI model for chemical structures. Transformer-based neural network architectures, which have become available only in the last several years, allow researchers to leverage massive datasets using self-supervised training methods, avoiding the need for manually labeled examples during pre-training.